Prevalence and determinants of anxiety and depression in long-term breast cancer survivors.
Anxiety
Breast cancer
Cancer survivorship
Depression
Hospital anxiety and depression scale
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
09 02 2022
09 02 2022
Historique:
received:
13
12
2020
accepted:
26
01
2022
entrez:
10
2
2022
pubmed:
11
2
2022
medline:
12
4
2022
Statut:
epublish
Résumé
There is a significant number of long-term breast cancer survivors in Germany. However, research on the psychological challenges of cancer survivors is limited. This analysis describes prevalence, development and determinants of depression and anxiety 5 to 6 years after diagnosis and identifies predictors for an increase of anxiety and depression over time. Data from 164 women was collected by survey and tumour documentation during post-operative hospital stay, 40 weeks and 5 to 6 years after diagnosis. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale. Sankey-diagrams were created for visual presentation of prevalence over time. Logistic and linear regression models were calculated to identify determinants of anxiety and depression. Respondents had higher levels of depression and anxiety 5 to 6 years than 40 weeks after the diagnosis. Lower vocational status and having children were associated with depression, surgery type was correlated with anxiety, and age, as well as comorbidities, were predictors for both anxiety and depression 5 to 6 years after diagnosis. An increase of depression over time was more likely when having children and comorbidities. An increase in anxiety was less likely after cancer recurrence. Findings highlight that anxiety and depression are relevant burdens for breast cancer survivors in Germany. Several sociodemographic and clinical predictors are identified. There is need for psychosocial support after acute treatment and in the long-term. Research on psychological burdens of long-term breast cancer survivors in the identified vulnerable groups is needed.
Sections du résumé
BACKGROUND
There is a significant number of long-term breast cancer survivors in Germany. However, research on the psychological challenges of cancer survivors is limited. This analysis describes prevalence, development and determinants of depression and anxiety 5 to 6 years after diagnosis and identifies predictors for an increase of anxiety and depression over time.
METHODS
Data from 164 women was collected by survey and tumour documentation during post-operative hospital stay, 40 weeks and 5 to 6 years after diagnosis. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale. Sankey-diagrams were created for visual presentation of prevalence over time. Logistic and linear regression models were calculated to identify determinants of anxiety and depression.
RESULTS
Respondents had higher levels of depression and anxiety 5 to 6 years than 40 weeks after the diagnosis. Lower vocational status and having children were associated with depression, surgery type was correlated with anxiety, and age, as well as comorbidities, were predictors for both anxiety and depression 5 to 6 years after diagnosis. An increase of depression over time was more likely when having children and comorbidities. An increase in anxiety was less likely after cancer recurrence.
CONCLUSIONS
Findings highlight that anxiety and depression are relevant burdens for breast cancer survivors in Germany. Several sociodemographic and clinical predictors are identified. There is need for psychosocial support after acute treatment and in the long-term. Research on psychological burdens of long-term breast cancer survivors in the identified vulnerable groups is needed.
Identifiants
pubmed: 35139815
doi: 10.1186/s12888-022-03735-3
pii: 10.1186/s12888-022-03735-3
pmc: PMC8827186
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101Informations de copyright
© 2022. The Author(s).
Références
Support Care Cancer. 2019 Jan;27(1):57-67
pubmed: 30225571
BMC Cancer. 2017 May 19;17(1):347
pubmed: 28526007
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Eur J Oncol Nurs. 2016 Apr;21:205-11
pubmed: 26521054
Breast Care (Basel). 2020 Feb;15(1):22-29
pubmed: 32231494
Psychosomatics. 2018 May - Jun;59(3):251-258
pubmed: 29525523
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1789-95
pubmed: 26377192
Mol Psychiatry. 2020 Jul;25(7):1487-1499
pubmed: 31745237
Breast Cancer Res Treat. 2017 Sep;165(2):229-245
pubmed: 28553684
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Int J Methods Psychiatr Res. 2015 Dec;24(4):305-13
pubmed: 26184561
J Cancer Surviv. 2020 Aug;14(4):504-517
pubmed: 32162194
J Psychosom Res. 2011 Aug;71(2):74-8
pubmed: 21767686
Int J Evid Based Healthc. 2011 Sep;9(3):215-35
pubmed: 21884450
Cancer. 2015 Mar 15;121(6):935-42
pubmed: 25377593
Support Care Cancer. 2011 Dec;19(12):1899-908
pubmed: 21898134
Support Care Cancer. 2020 Jan;28(1):211-220
pubmed: 31001695
Sch Inq Nurs Pract. 1998 Spring;12(1):33-41
pubmed: 9805470
Eur J Pain. 2017 Aug;21(7):1144-1153
pubmed: 28169489
BMJ Open. 2019 Dec 23;9(12):e033533
pubmed: 31874892
Int J Methods Psychiatr Res. 2014 Sep;23(3):304-19
pubmed: 24729411
Eur J Cancer. 2012 Nov;48(17):3150-6
pubmed: 22695071
Patient Educ Couns. 2016 Sep;99(9):1511-8
pubmed: 27378079
Med Clin North Am. 2017 Nov;101(6):1099-1113
pubmed: 28992857
Psychooncology. 2012 Mar;21(3):229-38
pubmed: 21919120
Maturitas. 2015 Sep;82(1):100-8
pubmed: 25998574
Patient Educ Couns. 2016 May;99(5):855-62
pubmed: 26742608
Cancer Epidemiol. 2018 Aug;55:123-129
pubmed: 29940418
Psychooncology. 2019 Oct;28(10):2033-2041
pubmed: 31364222
Crit Rev Oncol Hematol. 2011 Feb;77(2):109-30
pubmed: 20117019
BMJ Support Palliat Care. 2015 Dec;5(4):358-65
pubmed: 24644176
Breast Cancer. 2020 Mar;27(2):166-178
pubmed: 31828585
Psychooncology. 2014 May;23(5):547-54
pubmed: 24293081
J Psychosom Res. 2008 Apr;64(4):383-91
pubmed: 18374737
Psychother Psychosom Med Psychol. 2007 Jul;57(7):273-80
pubmed: 17377888
Cancer Nurs. 2010 Mar-Apr;33(2):110-8
pubmed: 20142737
BMC Cancer. 2019 Oct 11;19(1):943
pubmed: 31604468
J Natl Cancer Inst. 2018 Dec 1;110(12):1311-1327
pubmed: 30403799
Psychooncology. 2009 Dec;18(12):1273-80
pubmed: 19267364
Support Care Cancer. 2021 Dec;29(12):7647-7657
pubmed: 34137933